NEWSAR
Multi-perspective news intelligence
Bayer

Bayer

Organization Company

Bayer AG: Pharma & Agrochemical giant facing legal battles, pricing pressures, and investor shifts.

Mentions:4
7 Days:0

About

Bayer AG, a German multinational pharmaceutical and agricultural biotechnology company, is currently facing scrutiny and challenges across various fronts. Recent news highlights legal battles surrounding its Roundup weedkiller, with the Supreme Court hearing an appeal to block thousands of lawsuits. The company's CEO met with the EPA regarding this litigation. Furthermore, Bayer is advocating for higher drug prices in Europe, aligning with US interests, which is meeting resistance. An activist investor has exited their position in Bayer, causing a drop in the company's stock price. The company's historical context is also relevant, as exemplified by the Goethe University occupying the former IG-Farben-Haus, a building with a complex and controversial past. These events underscore Bayer's ongoing navigation of legal, economic, and historical complexities.
Last updated: June 28, 2026